Dose Escalation to Intra-prostatic Tumour Nodules in Localised Prostate Cancer
Dose Escalation to Intra-prostatic Tumour Nodules in Localised Prostate Cancer
To assess the toxicity and feasibility of a dose escalated intensity-modulated radiotherapy boost to tumour nodules within the prostate using anatomical and functional MR imaging to identify tumour. The aim is to maintain current levels of late toxicity. (from UKCRN Portfolio)Additional lay summaries...

100 patients to be recruited and have MRI scans to diagnose intra-prostatic tumour nodules. 50% of patients expected to have lesions and so 50 patients to be treated with a radiotherapy boost
Radiotherapy boost: A dose escalated external beam radiotherapy boost to intraprostatic tumour nodules within the prostate gland; Follow Up Length: 60 month(s); Study Entry : Registration only

The UKCTG information is designed to inform you of existing trials. If you wish
to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.

Please note: Trial data is sourced from multiple external providers and as such UKCTG is not responsible for, and cannot guarantee, the accuracy of data, including Location information. Please contact us if you have any query regarding the quality of trial records.